Patents by Inventor Shimon Marom

Shimon Marom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8101736
    Abstract: An isolated polypeptide comprising, contiguously, a first amino acid sequence being at least 90% homologous to amino acid coordinates 1-398 of SEQ ID NO: 2, a tryptophan residue and a second amino acid sequence being at least 90% homologous to amino acid coordinates 400-523 of SEQ ID NO:2. Also provided are polynucleotide sequences encoding this polypeptide and uses of same in the treatment of medical conditions associated with ion channel insufficiency.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: January 24, 2012
    Assignee: GeneGrafts Ltd.
    Inventors: Tal Bresler, Yair Feld, Reem Miari, Lior Gepstein, Shimon Marom
  • Patent number: 8007779
    Abstract: Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided.
    Type: Grant
    Filed: January 21, 2009
    Date of Patent: August 30, 2011
    Assignee: GeneGrafts Ltd.
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom
  • Publication number: 20100297083
    Abstract: An isolated polypeptide comprising, contiguously, a first amino acid sequence being at least 90% homologous to amino acid coordinates 1-398 of SEQ ID NO: 2, a tryptophan residue and a second amino acid sequence being at least 90% homologous to amino acid coordinates 400-523 of SEQ ID NO: 2. Also provided are polynucleotide sequences encoding this polypeptide and uses of same in the treatment of medical conditions associated with ion channel insufficiency.
    Type: Application
    Filed: December 12, 2006
    Publication date: November 25, 2010
    Applicant: GeneGrafts Ltd.
    Inventors: Tal Bresler, Yair Feld, Reem Miari, Lior Gepstein, Shimon Marom
  • Publication number: 20100015105
    Abstract: A method of treating schizophrenia in a subject in need thereof is provided. The method comprising, administering to the subject a therapeutically effective amount of cells expressing at least one exogenous polypeptide forming a connexin channel and/or a hyperpolarizing ion channel, thereby treating the schizophrenia in the subject.
    Type: Application
    Filed: December 25, 2007
    Publication date: January 21, 2010
    Inventors: Shimon Marom, Zoya Gluzman, Yair Feld
  • Publication number: 20090257990
    Abstract: Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 15, 2009
    Applicant: GeneGrafts Ltd.
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom
  • Patent number: 7499894
    Abstract: A method of training a biological neural network using a controller, comprising: applying a cycle comprising: stimulating a neural network by said controller applying at least an input signal to the network; detecting an output response of the network by said controller; and modifying said stimulation by said controller for at least a period of time if said response matches a desired at least approximate response; and repeating said cycle of stimulation, detection and modification at least one more time until said neural network is trained to generate a desired output response for said input signal.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: March 3, 2009
    Inventors: Shimon Marom, Goded Shahaf, Benny Rousso, Shlomo Ben Haim
  • Patent number: 7491385
    Abstract: Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: February 17, 2009
    Assignee: GeneGrafts Ltd.
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom
  • Publication number: 20080112927
    Abstract: A method of treating a movement disorder in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of cells capable of modifying a neuronal discharge of the subject, thereby treating the movement disorder in the subject, wherein said administering is effected at a site selected from the group consisting of internal globus pallidus, subthalamic nucleus and substantia nigra pars reticulate.
    Type: Application
    Filed: October 22, 2007
    Publication date: May 15, 2008
    Applicant: GeneGrafts Ltd.
    Inventors: Yair Feld, Shimon Marom
  • Patent number: 7294333
    Abstract: A method of modifying the electrophysiological function of an excitable tissue region of an individual is provided. The method includes the step of implanting cells into the excitable tissue region. Each implanted cell is (a) capable of forming gap junctions with at least one cell of the excitable tissue region; and (b) capable of forming a functional ion channel or transporter, wherein the functional ion channel or transporter is capable of modifying the electrophysiological function of the excitable tissue region.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 13, 2007
    Assignee: GeneGrafts Ltd.
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom, Meira Frank
  • Publication number: 20070060812
    Abstract: Apparatus (18) is provided for sensing electrical activity of a pancreas (20) of a patient. The apparatus (18) includes a set of one or more electrodes (100), adapted to be coupled to the pancreas (20), and to generate activity signals indicative of electrical activity of pancreatic cells which are in a plurality of islets of the pancreas (20). The apparatus (18) also includes a control unit (90), adapted to receive the activity signals, and to generate an output signal responsive thereto.
    Type: Application
    Filed: October 24, 2002
    Publication date: March 15, 2007
    Applicant: METACURE N.V.
    Inventors: Tamar Harel, Tamir Levi, Yuval Mika, Offer Glassberg, Nissim Darvish, Radwan Khawaled, Shimon Marom
  • Publication number: 20050008628
    Abstract: Polynucleotide expression constructs, populations of cells and methods of treating diseases caused by dysfunction in, or damage to, excitable tissues are provided.
    Type: Application
    Filed: August 17, 2004
    Publication date: January 13, 2005
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom
  • Publication number: 20040131998
    Abstract: A method of training a biological neural network using a controller, comprising:
    Type: Application
    Filed: September 15, 2003
    Publication date: July 8, 2004
    Inventors: Shimon Marom, Goded Shahaf, Benny Rousso, Shlomo Ben Haim
  • Publication number: 20040029148
    Abstract: A method of modifying the electrophysiological function of an excitable tissue region of an individual is provided. The method includes the step of implanting cells into the excitable tissue region. Each implanted cell is (a) capable of forming gap junctions with at least one cell of the excitable tissue region; and (b) capable of forming a functional ion channel or transporter, wherein the functional ion channel or transporter is capable of modifying the electrophysiological function of the excitable tissue region.
    Type: Application
    Filed: April 21, 2003
    Publication date: February 12, 2004
    Inventors: Yair Feld, Lior Gepstein, Shimon Marom, Meira Frank